Alexandria Hammond
Stock Analyst at B of A Securities
(0.77)
# 2355
Out of 5,358 analysts
16
Total ratings
60.00%
Success rate
-0.98%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
AKRO Akero Therapeutics | Maintains: Strong Buy | 63 64 | 54.27 | 17.93% | 4 | May 27, 2025 | |
REGN Regeneron Pharmaceut... | Initiates Coverage On: Outperform | 1150 | 493.12 | 133.21% | 1 | Nov 15, 2024 | |
PFE Pfizer | Initiates Coverage On: Underperform | 25 | 23.34 | 7.11% | 1 | Nov 15, 2024 | |
MRNA Moderna | Initiates Coverage On: Underperform | 40 | 27.47 | 45.61% | 1 | Nov 15, 2024 | |
MRK Merck & Co | Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 1000 | 770.02 | 29.87% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 190 | 155.02 | 22.56% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 110 | 112.44 | -2.17% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 205 | 189.9 | 7.95% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | 150 | 278.06 | -46.05% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 30 | 10.27 | 192.11% | 1 | Apr 22, 2024 |